{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:28:10Z","timestamp":1782530890652,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00213-024-06675-w","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:15:36Z","timestamp":1724444136000},"page":"2485-2495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of (S)-T1 and (S)-T2 ligands targeting \u03b13\u03b24 nAChR as potential nicotine addiction pharmacotherapy"],"prefix":"10.1007","volume":"241","author":[{"given":"Saranda","family":"Nianpanich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchanee","family":"Rodsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridho","family":"Islamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patanachai","family":"Limpikirati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanundorn","family":"Thanusuwannasak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opa","family":"Vajragupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apinan","family":"Kanasuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-0067","authenticated-orcid":false,"given":"Jiradanai","family":"Sarasamkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"6675_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.05.025","volume":"138","author":"D Bagdas","year":"2018","unstructured":"Bagdas D, Alkhlaif Y, Jackson A, Carroll FI, Ditre JW, Damaj MI (2018) New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice. Neuropharmacology 138:72\u201379. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.05.025","journal-title":"Neuropharmacology"},{"key":"6675_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31\u201343. https:\/\/doi.org\/10.1007\/s002130000569","journal-title":"Psychopharmacology"},{"key":"6675_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1124\/pr.115.011163","volume":"68","author":"JB Becker","year":"2016","unstructured":"Becker JB, Koob GF (2016) Sex differences in animal models: focus on addiction. Pharmacol Rev 68:242\u2013263. https:\/\/doi.org\/10.1124\/pr.115.011163","journal-title":"Pharmacol Rev"},{"key":"6675_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12971-017-0116-0","volume":"15","author":"AR Benli","year":"2017","unstructured":"Benli AR, Erturhan S, Oruc MA, Kalpakci P, Sunay D, Demirel Y (2017) A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme. Tob Induc Dis 15:10. https:\/\/doi.org\/10.1186\/s12971-017-0116-0","journal-title":"Tob Induc Dis"},{"key":"6675_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/sj.mp.4002154","volume":"13","author":"W Berrettini","year":"2008","unstructured":"Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H, Waterworth D, Muglia P, Mooser V (2008) \u03b1-5\/\u03b1-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13:368\u2013373. https:\/\/doi.org\/10.1038\/sj.mp.4002154","journal-title":"Mol Psychiatry"},{"key":"6675_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1176\/appi.ajp.2008.07111711","volume":"165","author":"LJ Bierut","year":"2008","unstructured":"Bierut LJ, Stitzel JA, Wang JC et al (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163\u20131171. https:\/\/doi.org\/10.1176\/appi.ajp.2008.07111711","journal-title":"Am J Psychiatry"},{"key":"6675_CR7","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1038\/npp.2014.129","volume":"39","author":"R Bourdy","year":"2014","unstructured":"Bourdy R, S\u00e1nchez-Catal\u00e1n MJ, Kaufling J et al (2014) Control of the nigrostriatal dopamine neuron activity and motor function by the tail of the ventral tegmental area. Neuropsychopharmacology 39:2788\u20132798. https:\/\/doi.org\/10.1038\/npp.2014.129","journal-title":"Neuropsychopharmacology"},{"key":"6675_CR8","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/nprot.2006.279","volume":"1","author":"CL Cunningham","year":"2006","unstructured":"Cunningham CL, Gremel CM, Groblewski PA (2006) Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1:1662\u20131670. https:\/\/doi.org\/10.1038\/nprot.2006.279","journal-title":"Nat Protoc"},{"key":"6675_CR9","unstructured":"D'Souza MS, Markou A (2011) Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract 6:4\u201316. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/pmc3188825. Accessed 05 Jan 2023"},{"key":"6675_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/s0896-6273(00)80112-9","volume":"16","author":"JA Dani","year":"1996","unstructured":"Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905\u2013908. https:\/\/doi.org\/10.1016\/s0896-6273(00)80112-9","journal-title":"Neuron"},{"key":"6675_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbr.2016.04.008","volume":"307","author":"BL Eggan","year":"2016","unstructured":"Eggan BL, McCallum SE (2016) 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine. Behav Brain Res 307:186\u2013193. https:\/\/doi.org\/10.1016\/j.bbr.2016.04.008","journal-title":"Behav Brain Res"},{"key":"6675_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1523\/jneurosci.0127-19.2020","volume":"41","author":"KS Elayouby","year":"2021","unstructured":"Elayouby KS, Ishikawa M, Dukes AJ, Smith ACW, Lu Q, Fowler CD, Kenny PJ (2021) \u03b13* Nicotinic acetylcholine receptors in the habenula-interpeduncular nucleus circuit regulate nicotine intake. J Neurosci 41:1779\u20131787. https:\/\/doi.org\/10.1523\/jneurosci.0127-19.2020","journal-title":"J Neurosci"},{"key":"6675_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/fbp.0b013e32830c360e","volume":"19","author":"CD Fowler","year":"2008","unstructured":"Fowler CD, Arends MA, Kenny PJ (2008) Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol 19:461\u2013484. https:\/\/doi.org\/10.1097\/fbp.0b013e32830c360e","journal-title":"Behav Pharmacol"},{"key":"6675_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nature09797","volume":"471","author":"CD Fowler","year":"2011","unstructured":"Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ (2011) Habenular \u03b15 nicotinic receptor subunit signalling controls nicotine intake. Nature 471:597\u2013601. https:\/\/doi.org\/10.1038\/nature09797","journal-title":"Nature"},{"key":"6675_CR15","unstructured":"Fu Y, Matta SG, Gao W, Brower VG, Sharp BM (2000) Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 294:458\u2013465. https:\/\/pubmed.ncbi.nlm.nih.gov\/10900219. Accessed 13 Aug 2022"},{"key":"6675_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejphar.2008.09.038","volume":"599","author":"S Glick","year":"2008","unstructured":"Glick S, Sell E, Maisonneuve I (2008) Brain regions mediating \u03b13\u03b24 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration. Eur J Pharmacol 599:91\u201395. https:\/\/doi.org\/10.1016\/j.ejphar.2008.09.038","journal-title":"Eur J Pharmacol"},{"key":"6675_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2011.08.001","volume":"669","author":"SD Glick","year":"2011","unstructured":"Glick SD, Sell EM, McCallum SE, Maisonneuve IM (2011) Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on nicotine self-administration. Eur J Pharmacol 669:71\u201375. https:\/\/doi.org\/10.1016\/j.ejphar.2011.08.001","journal-title":"Eur J Pharmacol"},{"key":"6675_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","volume":"78","author":"C Gotti","year":"2009","unstructured":"Gotti C, Clementi F, Fornari A et al (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78:703\u2013711. https:\/\/doi.org\/10.1016\/j.bcp.2009.05.024","journal-title":"Biochem Pharmacol"},{"key":"6675_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8994-2","volume-title":"Pre-clinical models: Techniques and protocols","author":"PC Guest","year":"2019","unstructured":"Guest PC (2019) Pre-clinical models: Techniques and protocols. Springer, New York"},{"key":"6675_CR20","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1111\/j.1460-9568.2006.05217.x","volume":"24","author":"K Guillem","year":"2006","unstructured":"Guillem K, Vouillac AMR, Parsons LH, Koop GF, Cador M, Stinus L (2006) Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci 24:3532\u20133540. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05217.x","journal-title":"Eur J Neurosci"},{"key":"6675_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/ntr\/ntp076","volume":"11","author":"C Isiegas","year":"2009","unstructured":"Isiegas C, Mague SD, Blendy JA (2009) Sex differences in response to nicotine in C57Bl\/6:129SvEv mice. Nicotine Tob Res 11:851\u2013858. https:\/\/doi.org\/10.1093\/ntr\/ntp076","journal-title":"Nicotine Tob Res"},{"key":"6675_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s0091-3057(01)00651-7","volume":"70","author":"PJ Kenny","year":"2001","unstructured":"Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70:531\u2013549. https:\/\/doi.org\/10.1016\/s0091-3057(01)00651-7","journal-title":"Pharmacol Biochem Behav"},{"key":"6675_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bcp.2015.08.083","volume":"97","author":"TV Khroyan","year":"2015","unstructured":"Khroyan TV, Yasuda D, Toll L, Pogar WE, Zeveri NT (2015) High affinity \u03b13\u03b24 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice. Biochem Pharmacol 97:531\u2013541. https:\/\/doi.org\/10.1016\/j.bcp.2015.08.083","journal-title":"Biochem Pharmacol"},{"key":"6675_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neulet.2011.02.035","volume":"493","author":"J Kleijn","year":"2011","unstructured":"Kleijn J, Folgering JHA, van der Hart MCG, Rollema H, Cremers TIFH, Westerink BHC (2011) Direct effect of nicotine on mesolimbic dopamine release in rat nucleus accumbens shell. Neurosci Lett 493:55\u201358. https:\/\/doi.org\/10.1016\/j.neulet.2011.02.035","journal-title":"Neurosci Lett"},{"key":"6675_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00100","volume":"10","author":"HW Lee","year":"2019","unstructured":"Lee HW, Yang SH, Kim JY, Kim H (2019) The role of the medial habenula cholinergic system in addiction and emotion-associated behaviors. Front Psychiatry 10:100. https:\/\/doi.org\/10.3389\/fpsyt.2019.00100","journal-title":"Front Psychiatry"},{"key":"6675_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/md18120646","volume":"18","author":"X Li","year":"2020","unstructured":"Li X, You S, Xiong J, Qiao Y, Yu J, Zhangsun D, Luo S (2020) \u03b1-Conotoxin TxID and [S9K]TxID, \u03b13\u03b24 nAChR antagonists, attenuate expression and reinstatement of nicotine-induced conditioned place preference in mice. Mar Drug 18:646. https:\/\/doi.org\/10.3390\/md18120646","journal-title":"Mar Drug"},{"key":"6675_CR27","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1098\/rstb.2008.0095","volume":"363","author":"A Markou","year":"2008","unstructured":"Markou A (2008) Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci 363:3159\u20133168. https:\/\/doi.org\/10.1098\/rstb.2008.0095","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"6675_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuropharm.2012.04.015","volume":"63","author":"SE McCallum","year":"2012","unstructured":"McCallum SE, Cowe MA, Lewis SW, Glick SD (2012) \u03b13\u03b24 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo. Neuropharmacology 63:434\u2013440. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.04.015","journal-title":"Neuropharmacology"},{"issue":"Suppl 2","key":"6675_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/jnc.14008","volume":"142","author":"I McLaughlin","year":"2017","unstructured":"McLaughlin I, Dani JA, De Biasi M (2017) The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation. J Neurochem 142(Suppl 2):130\u2013143. https:\/\/doi.org\/10.1111\/jnc.14008","journal-title":"J Neurochem"},{"key":"6675_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pbb.2013.04.005","volume":"108","author":"JR Nickell","year":"2013","unstructured":"Nickell JR, Grinevich VP, Siripurapu KB, Smith AM, Dwoskin LP (2013) Potential therapeutic uses of mecamylamine and its stereoisomers. Pharmacol Biochem Behav 108:28\u201343. https:\/\/doi.org\/10.1016\/j.pbb.2013.04.005","journal-title":"Pharmacol Biochem Behav"},{"key":"6675_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1046\/j.1471-4159.2002.00951.x","volume":"82","author":"DC Perry","year":"2002","unstructured":"Perry DC, Xiao Y, Nguyen HN, Musachio JL, D\u00e1vila-Garc\u00eda MI, Kellar KJ (2002) Measuring nicotinic receptors with characteristics of \u03b14\u03b22, \u03b13\u03b22 and \u03b13\u03b24 subtypes in rat tissues by autoradiography. J Neurochem 82:468\u2013481. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00951.x","journal-title":"J Neurochem"},{"key":"6675_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012112","volume":"3","author":"MR Picciotto","year":"2013","unstructured":"Picciotto MR, Kenny PJ (2013) Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb Perspect Med 3:a012112. https:\/\/doi.org\/10.1101\/cshperspect.a012112","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6675_CR33","unstructured":"Prus AJ, James JR, Rosecrans JA, Rosecrans JA (2009) Conditioned place preference. In Buccafusco JJ (ed) Methods of behavior analysis in neuroscience. 2nd edn. CRC Press\/Taylor & Francis, Boca Raton (FL). http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk5229\/. Accessed 08 Aug 2022"},{"key":"6675_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.119","volume":"1","author":"AK Radke","year":"2021","unstructured":"Radke AK, Sneddon EA, Monroe SC (2021) Studying sex differences in rodent models of addictive behavior. Current Protocols 1:e119. https:\/\/doi.org\/10.1002\/cpz1.119","journal-title":"Current Protocols"},{"key":"6675_CR35","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/j.1742-1241.2008.01885.x","volume":"62","author":"VI Reus","year":"2008","unstructured":"Reus VI, Smith BJ (2008) Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines. Int J Clin Pract 62:1753\u20131768. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01885.x","journal-title":"Int J Clin Pract"},{"key":"6675_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev.psych.54.101601.145237","volume":"54","author":"TE Robinson","year":"2003","unstructured":"Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25\u201353. https:\/\/doi.org\/10.1146\/annurev.psych.54.101601.145237","journal-title":"Annu Rev Psychol"},{"key":"6675_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","volume":"184","author":"JE Rose","year":"2006","unstructured":"Rose JE (2006) Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 184:274\u2013285. https:\/\/doi.org\/10.1007\/s00213-005-0250-x","journal-title":"Psychopharmacology"},{"key":"6675_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ajmg.b.30828","volume":"150","author":"NL Saccone","year":"2009","unstructured":"Saccone NL, Saccone SF, Hinrichs AL, Hinrichs AL, Stitzel JA et al (2009a) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet 150:453\u2013466. https:\/\/doi.org\/10.1002\/ajmg.b.30828","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"6675_CR39","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1158\/0008-5472.can-09-0786","volume":"69","author":"NL Saccone","year":"2009","unstructured":"Saccone NL, Wang JC, Breslau N, Johnson EO et al (2009b) The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 69:6848\u20136856. https:\/\/doi.org\/10.1158\/0008-5472.can-09-0786","journal-title":"Cancer Res"},{"key":"6675_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.neuropharm.2004.05.002","volume":"47","author":"R Salas","year":"2004","unstructured":"Salas R, Cook KD, Bassetto L, De Biasi M (2004) The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47:401\u2013407. https:\/\/doi.org\/10.1016\/j.neuropharm.2004.05.002","journal-title":"Neuropharmacology"},{"key":"6675_CR41","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1523\/jneurosci.4934-08.2009","volume":"29","author":"R Salas","year":"2009","unstructured":"Salas R, Sturm R, Boulter J, De Biasi M (2009) Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 29:3014\u20133018. https:\/\/doi.org\/10.1523\/jneurosci.4934-08.2009","journal-title":"J Neurosci"},{"key":"6675_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.apradiso.2017.03.015","volume":"124","author":"J Sarasamkan","year":"2017","unstructured":"Sarasamkan J, Fischer S, Deuther-Conrad W et al (2017) Radiosynthesis of (S)-[(18)F]T1: The first PET radioligand for molecular imaging of alpha3beta4 nicotinic acetylcholine receptors. Appl Radiat Isot 124:106\u2013113. https:\/\/doi.org\/10.1016\/j.apradiso.2017.03.015","journal-title":"Appl Radiat Isot"},{"key":"6675_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1021\/acsmedchemlett.6b00146","volume":"7","author":"J Sarasamkan","year":"2016","unstructured":"Sarasamkan J, Scheunemann M, Apaijai N et al (2016) Varying chirality across nicotinic acetylcholine receptor subtypes: selective binding of quinuclidine triazole compounds. ACS Med Chem Lett 7:890\u2013895. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00146","journal-title":"ACS Med Chem Lett"},{"key":"6675_CR44","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.biopsych.2007.10.024","volume":"63","author":"IR Schlaepfer","year":"2008","unstructured":"Schlaepfer IR, Hoft NR, Collins AC et al (2008) The CHRNA5\/A3\/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63:1039\u20131046. https:\/\/doi.org\/10.1016\/j.biopsych.2007.10.024","journal-title":"Biol Psychiatry"},{"key":"6675_CR45","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/j.1360-0443.2008.02279.x","volume":"103","author":"R Sherva","year":"2008","unstructured":"Sherva R, Wilhelmsen K, Pomerleau CS et al (2008) Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with \u201cpleasurable buzz\u201d during early experimentation with smoking. Addiction 103:1544\u20131552. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02279.x","journal-title":"Addiction"},{"key":"6675_CR46","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1158\/1055-9965.epi-08-0585","volume":"17","author":"VL Stevens","year":"2008","unstructured":"Stevens VL, Bierut LJ, Talbot JT et al (2008) Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 17:3517\u20133525. https:\/\/doi.org\/10.1158\/1055-9965.epi-08-0585","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6675_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2019.152325","volume":"429","author":"S Suzuki","year":"2020","unstructured":"Suzuki S, Cohen SM, Arnold LL et al (2020) Cotinine, a major nicotine metabolite, induces cell proliferation on urothelium in vitro and in vivo. Toxicology 429:152325. https:\/\/doi.org\/10.1016\/j.tox.2019.152325","journal-title":"Toxicology"},{"key":"6675_CR48","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/npp.2011.322","volume":"37","author":"L Toll","year":"2012","unstructured":"Toll L, Zaveri NT, Polgar WE et al (2012) AT-1001: a high affinity and selective \u03b13\u03b24 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology 37:1367\u20131376. https:\/\/doi.org\/10.1038\/npp.2011.322","journal-title":"Neuropsychopharmacology"},{"key":"6675_CR49","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.neuropharm.2007.02.001","volume":"52","author":"AS Vill\u00e9gier","year":"2007","unstructured":"Vill\u00e9gier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM (2007) Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52:1415\u20131425. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.02.001","journal-title":"Neuropharmacology"},{"key":"6675_CR50","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1523\/jneurosci.1544-06.2006","volume":"26","author":"ND Volkow","year":"2006","unstructured":"Volkow ND, Wang GJ, Telang F et al (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26:6583\u20136588. https:\/\/doi.org\/10.1523\/jneurosci.1544-06.2006","journal-title":"J Neurosci"},{"key":"6675_CR51","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/ntr\/ntr118","volume":"13","author":"JJ Ware","year":"2011","unstructured":"Ware JJ, van den Bree MBM, Munaf\u00f2 MR (2011) Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. Nicotine Tob Res 13:1167\u20131175. https:\/\/doi.org\/10.1093\/ntr\/ntr118","journal-title":"Nicotine Tob Res"},{"key":"6675_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000125","volume":"4","author":"RB Weiss","year":"2008","unstructured":"Weiss RB, Baker TB, Cannon DS et al (2008) A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 4:e1000125. https:\/\/doi.org\/10.1371\/journal.pgen.1000125","journal-title":"PLoS Genet"},{"key":"6675_CR53","unstructured":"World Health Organization (2023) Research for international tobacco control. WHO report on the global tobacco epidemic; World Health Organization. Geneva, Switzerland"},{"key":"6675_CR54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/pharmrev.121.000299","volume":"74","author":"L Wills","year":"2022","unstructured":"Wills L, Ables JL, Braunscheidel KM et al (2022) Neurobiological mechanisms of nicotine reward and aversion. Pharmacol Rev 74:271\u2013310. https:\/\/doi.org\/10.1124\/pharmrev.121.000299","journal-title":"Pharmacol Rev"},{"key":"6675_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108256","volume":"177","author":"RE Wittenberg","year":"2020","unstructured":"Wittenberg RE, Wolfman SL, De Biasi M et al (2020) Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. Neuropharmacology 177:108256. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108256","journal-title":"Neuropharmacology"},{"key":"6675_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuropharm.2013.09.023","volume":"77","author":"J Wu","year":"2014","unstructured":"Wu J, Perry DC, Bupp JE et al (2014) [125I]AT-1012, a new high affinity radioligand for the \u03b13\u03b24 nicotinic acetylcholine receptors. Neuropharmacology 77:193\u2013199. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.09.023","journal-title":"Neuropharmacology"},{"key":"6675_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ntr\/ntu170","volume":"17","author":"NT Zaveri","year":"2015","unstructured":"Zaveri NT, Bertrand S, Yasuda D et al (2015) Functional characterization of AT-1001, an \u03b13\u03b24 nicotinic acetylcholine receptor ligand, at human \u03b13\u03b24 and \u03b14\u03b22 nAChR. Nicotine Tob Res 17:361\u2013367. https:\/\/doi.org\/10.1093\/ntr\/ntu170","journal-title":"Nicotine Tob Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06675-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T06:04:08Z","timestamp":1731737048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06675-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6675"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06675-w","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Completing interests"}}]}}